Literature DB >> 6608569

Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities.

J E Estes, W J Pledger, G Y Gillespie.   

Abstract

P388D1, a mouse macrophagelike cell line, was adapted to grow continuously in an unsupplemented, serum-free culture medium and continued to elaborate substances that were mitogenic for quiescent mouse fibroblasts (BALB/c 3T3 cells) and for thymocytes suboptimally stimulated with lectins. We have previously described [37] the fibroblast mitogenic activity as a macrophage-derived competence factor (MDCF). Serum-free, macrophage-conditioned culture medium was concentrated 1,000-fold by a combination of ultrafiltration (hollow fiber) and lyophilization. Concentrates of medium were subjected to gel filtration (Sephadex G-75 or G-150), and the fractions were assayed for mitogenic activity (MDCF) on density-arrested BALB/c 3T3 cells and for Interleukin-1 (IL-1) activity in suboptimally stimulated (Con A) mouse thymocytes. The apparent molecular weight (MW) of MDCF activity was estimated at 56,000 daltons, whereas the peak of IL-1 chromatographed at an apparent MW of 14-16K daltons. There was no detectable IL-1 activity in the MDCF fractions and no detectable MDCF in the IL-1 fractions. These data indicate that P388D1 cells produce both MDCF and IL-1 activities under continuous serum-free conditions and that the two activities are not identical. Stimulation of responsive mononuclear phagocytes with lipopolysaccharide and/or lymphokine-rich supernates resulted in a differential modulation of MDCF and IL-1 activities. Finally, antibody-purified IL-1 had no significant ability to stimulate DNA synthesis in quiescent fibroblasts at concentrations that were mitogenic for thymocytes. However, IL-1 did augment the mitogenic activity of suboptimal amounts of platelet-derived growth factor (PDGF), another competence factor. Further studies revealed that neither the generation nor the activity of MDCF was modulated by the presence of various inhibitors of proteolytic enzymes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608569     DOI: 10.1002/jlb.35.1.115

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production.

Authors:  S H Phan; S L Kunkel
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

2.  Macrophage modulation of retinal pigment epithelial cell migration and proliferation.

Authors:  B Kirchhof; E Kirchhof; S J Ryan; J F Dixon; B E Barton; N Sorgente
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Inhibition of collagen synthesis by interleukin-1 in three-dimensional collagen lattice cultures of fibroblasts.

Authors:  P Gillery; F Coustry; J P Pujol; J P Borel
Journal:  Experientia       Date:  1989-01-15

4.  Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.

Authors:  P B Bitterman; M D Wewers; S I Rennard; S Adelberg; R G Crystal
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Interleukin 1 modulates collagen accumulation by rat granulation tissue cells both in vivo and in vitro.

Authors:  M Laato; J Heino
Journal:  Experientia       Date:  1988-01-15

Review 6.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

7.  Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha.

Authors:  S C Thornton; S B Por; R Penny; M Richter; L Shelley; S N Breit
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

8.  Cerebrospinal fluid interleukin 1 like activity during chronic relapsing experimental allergic encephalomyelitis.

Authors:  J A Symons; R V Bundick; A J Suckling; M G Rumsby
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

9.  Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma.

Authors:  C I Sandborg; M A Berman; B S Andrews; G R Mirick; G J Friou
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

10.  Schistosomal egg granuloma-derived fibroblast-stimulating factor is apparently distinct from interleukin-1.

Authors:  S Prakash; C A Dinarello; K Danko; M J Stadecker; D J Wyler
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.